209 related articles for article (PubMed ID: 31754071)
1. Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma Agent.
Dinavahi SS; Gowda R; Gowda K; Bazewicz CG; Chirasani VR; Battu MB; Berg A; Dokholyan NV; Amin S; Robertson GP
Mol Cancer Ther; 2020 Feb; 19(2):447-459. PubMed ID: 31754071
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.
Dinavahi SS; Gowda R; Bazewicz CG; Battu MB; Lin JM; Chitren RJ; Pandey MK; Amin S; Robertson GP; Gowda K
Eur J Med Chem; 2020 Feb; 187():111962. PubMed ID: 31887569
[TBL] [Abstract][Full Text] [Related]
3. Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.
Makia NL; Bojang P; Falkner KC; Conklin DJ; Prough RA
Chem Biol Interact; 2011 May; 191(1-3):278-87. PubMed ID: 21256123
[TBL] [Abstract][Full Text] [Related]
4. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
5. Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells.
Townsend AJ; Leone-Kabler S; Haynes RL; Wu Y; Szweda L; Bunting KD
Chem Biol Interact; 2001 Jan; 130-132(1-3):261-73. PubMed ID: 11306050
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
Wu D; Mou YP; Chen K; Cai JQ; Zhou YC; Pan Y; Xu XW; Zhou W; Gao JQ; Chen DW; Zhang RC
Int J Oncol; 2016 Aug; 49(2):611-22. PubMed ID: 27279633
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors.
Grimley E; Cole AJ; Luong TT; McGonigal SC; Sinno S; Yang D; Bernstein KA; Buckanovich RJ
Theranostics; 2021; 11(8):3540-3551. PubMed ID: 33664846
[No Abstract] [Full Text] [Related]
8. Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics.
Dinavahi SS; Bazewicz CG; Gowda R; Robertson GP
Trends Pharmacol Sci; 2019 Oct; 40(10):774-789. PubMed ID: 31515079
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma.
Prasmickaite L; Engesaeter BØ; Skrbo N; Hellenes T; Kristian A; Oliver NK; Suo Z; Maelandsmo GM
PLoS One; 2010 May; 5(5):e10731. PubMed ID: 20505780
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
[TBL] [Abstract][Full Text] [Related]
11. Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance.
Zanoni M; Bravaccini S; Fabbri F; Arienti C
Front Med (Lausanne); 2022; 9():795762. PubMed ID: 35299840
[TBL] [Abstract][Full Text] [Related]
12. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
13. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
[TBL] [Abstract][Full Text] [Related]
14. Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures.
Saw YT; Yang J; Ng SK; Liu S; Singh S; Singh M; Welch WR; Tsuda H; Fong WP; Thompson D; Vasiliou V; Berkowitz RS; Ng SW
BMC Cancer; 2012 Aug; 12():329. PubMed ID: 22852552
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
16. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress.
Choudhary S; Xiao T; Vergara LA; Srivastava S; Nees D; Piatigorsky J; Ansari NH
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):259-67. PubMed ID: 15623782
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes.
Klyosov AA
Biochemistry; 1996 Apr; 35(14):4457-67. PubMed ID: 8605195
[TBL] [Abstract][Full Text] [Related]
18. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.
Zhou L; Sheng D; Wang D; Ma W; Deng Q; Deng L; Liu S
Cell Biol Toxicol; 2019 Apr; 35(2):161-177. PubMed ID: 30220009
[TBL] [Abstract][Full Text] [Related]
19. Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase.
Bunting KD; Lindahl R; Townsend AJ
J Biol Chem; 1994 Sep; 269(37):23197-203. PubMed ID: 8083225
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases.
Khanna M; Chen CH; Kimble-Hill A; Parajuli B; Perez-Miller S; Baskaran S; Kim J; Dria K; Vasiliou V; Mochly-Rosen D; Hurley TD
J Biol Chem; 2011 Dec; 286(50):43486-94. PubMed ID: 22021038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
